Patent classifications
A
A23
A23Y
A23Y2300/59
Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing <i>Bifidobacterium pseudocatenulatum </i>C-RAPO (KCTC13986BP) and <i>Bifidobacterium bifidum </i>ATT (KCTC13474BP)
Disclosed are Bifidobacterium pseudocatenulatum C-RAPO (KCTC13986BP) and Bifidobacterium bifidum ATT (KCTC13474BP) strains that have the effects of inhibiting sialoadenitis, which is a symptom of the Sjogren's syndrome, and inhibiting a reduction in saliva flow rate. Based on this, these strains can be used for prevention or treatment of Sjogren's syndrome and can be developed into food, health food and pharmaceuticals.